Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)

NCT00198367 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Cisplatin-Gemzar
DRUG: Cisplatin-Navelbine-Radiotherapy
DRUG: Carboplatin-Taxol-Radiotherapy

Sponsor

Hospices Civils de Lyon